Minsheng 丨 New domestic dual -price cervical cancer vaccine is about to be listed in Hunan

On July 30, the Hunan Province 2022 Cervical Cancer Prevention and Control Seminar held by the Provincial Association of Prevention Medical Association was held. The reporter learned from the conference that starting in mid -August, our province will usher in the new domestic bi -price cervical cancer vaccine developed by Zerun Bio, a subsidiary of Watson Bio, Yunnan, to effectively alleviate the current four -valent and nine -valent cervical cancer vaccine For the current situation, female friends who are eligible can make an appointment in relevant agencies.

Huang Yuelong, vice chairman and secretary -general of the Hunan Provincial Association of Prevention Medicine, said that cervical cancer is a malignant tumor that seriously threatens women's health and life safety. In 2020, there were 110,000 new cases of cervical cancer in my country and 60,000 cases of death. According to the results of tumor monitoring in Hunan Province, the incidence of cervical cancer in our province in 2021 ranks third in cancer, second only to lung cancer and breast cancer, as high as 26.17/100,000, and the mortality rate is fifth, second only to lung cancer and liver cancer. , Colorectal cancer, gastric cancer.

HPV infection is the main cause of cervical cancer. With the aging of the initial behavior, HPV infection shows a trend of youth. A study in a country in 37 cities in 37 cities in my country found that 15-19 years old was found. The infection rate of high -risk HPV in adolescents is as high as 30.55%, and the youngest age of cervical cancer is as low as 15 years old. It is recommended that young women inocus HPV vaccines as soon as possible, reduce the risk of HPV infection, reduce the probability of cervical cancer, and achieve the goal of eliminating cervical cancer proposed by WHO.

Gao Lidong, director of the Hunan Provincial Disease Prevention and Control Center, said that cervical cancer is a disease that seriously endangers the health of women and has become a global public health issue. Cervical cancer is also the only tumor with a clear cause of all malignant tumors at present. At present, there are also good first -level prevention weapons such as HPV vaccine.

my country has clearly stated that it will fully support the "Accelerating the Elimination of Cervical Cancer Global Strategy" proposed by the World Health Organization, that is, 90%of girls have completed the vaccination of human papilloma virus vaccines before the age of 15; 70%of women accept Screening for high -efficiency testing methods; 90%of women with cervical diseases were treated. Ms. Lu Meixiang, the Women's Federation of Hunan Province, introduced that the HPV vaccine needs to be vaccinated as much as possible before sexual behavior. The sooner, the better the vaccine effect. It is recommended to use girls who have not occurred at the age of 9-14 as the primary vaccination target to give priority to ensuring the high vaccination rate of the crowd. Early vaccination, early protection, early benefit.

It is understood that the listing of new domestic dual-price cervical cancer vaccines will provide strong support for the WTO's global elimination of cervical cancer targets and healthy China (2019-2030) cancer prevention operation in 2030. The vaccination of the vaccine adapting to women 9-30 years old is of great significance to achieve the WHO's global elimination of cervical cancer targets "90%of girls under 15-year-old girl under 15 years old and 15 years old.

All media reporter Li Qi intern, Sun Xin Yang Shao Correspondent Shi Ji

(First instance: Zhu Rong Second Trial: Peng Zhiguo Third Trial: Zhang Jun)

- END -